Milwaukee, WISCONSIN5 Active Studies

Pulmonary Hypertension Clinical Trials in Milwaukee, WISCONSIN

Find 5 actively recruiting pulmonary hypertension clinical trials in Milwaukee, WISCONSIN. Connect with local research sites and explore new treatment options.

5
Active Trials
5
Sponsors
539
Enrolling

Recruiting Pulmonary Hypertension Studies in Milwaukee

RecruitingMilwaukee, WISCONSINNCT05707377

A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy

The primary objectives of this study are: In Part 1 to evaluate the efficacy of zanubrutinib as measured by proteinuria reduction, and in Part 2 to evaluate the efficacy of zanubrutinib compared with ...

282 participants
BeiGene
View Study Details
RecruitingMilwaukee, WISCONSINNCT05783609

Epcoritamab and Rituximab for First-line Follicular Lymphoma

The purpose of this study is to determine how effective and safe the combination of rituximab and epcoritamab is in treating patients with Follicular Lymphoma (FL) and who have not received other trea...

100 participants
Reid Merryman, MD
View Study Details
RecruitingMilwaukee, WISCONSINNCT06457503

A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer

This study aims to investigate toripalimab with chemotherapy in participants with nasopharyngeal cancer....

100 participants
Coherus Oncology, Inc.
View Study Details
RecruitingMilwaukee, WISCONSINNCT05587712

Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)

The primary objectives of the study are to evaluate the safety and tolerability, and pharmacokinetics (PK) of sotatercept over 24 weeks of treatment in children ≥1 to \<18 years of age with PAH World ...

42 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingMilwaukee, WISCONSINNCT06679270

Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

This Phase 3 study is an Open Label Extension of the APG-20 Study To Evaluate the Long-term Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects with Partial Lipodystrophy...

15 participants
Amryt Pharma
View Study Details

About Pulmonary Hypertension Clinical Trials in Milwaukee

Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.

There are currently 5 pulmonary hypertension clinical trials recruiting participants in Milwaukee, WISCONSIN. These studies are seeking a combined 539 participants. Research is being sponsored by BeiGene, Reid Merryman, MD, Coherus Oncology, Inc. and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Hypertension Clinical Trials in Milwaukee — FAQ

Are there pulmonary hypertension clinical trials in Milwaukee?

Yes, there are 5 pulmonary hypertension clinical trials currently recruiting in Milwaukee, WISCONSIN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Milwaukee?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Milwaukee research site will contact you about next steps.

Are clinical trials in Milwaukee free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Milwaukee studies also compensate for your time and travel.

What pulmonary hypertension treatments are being tested?

The 5 active trials in Milwaukee are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.

Data updated March 2, 2026 from ClinicalTrials.gov